JC, Levitzki A, Martinez M, et al. Tyrosine kinase inhibition ameliorates : the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites. J Clin invest, 1997, 100:664-670. 5 Mizumoto M, Arii S, Furutani M, et al. NO as an indicator of portal hemodynamics and the role of iNOS in increased NO production in CCl4-induced live cirrhosis. J Surg Res, 1997, 70 :124-133.
6 Rockey DC, Chung JJ. Regulation of inducible nitric oxide synthase and nitric oxide hepatic injury and fibrogenesis. Am J Physiol, 1997, 273(1 Pt 1): g124-130.
7 Billiar TR, Curran RD, Stuchr DJ, et al. Evidence that activation of kupffer cells results in production of L-arginine metabolites that release cell-associated iron and inhibit hepatocyte protein synthsis. Surgery, 1989,106:364-372.
8 Bohlinger I, Leist M, Brsig J, et al. Interleukin-1 and nitric oxide protect against tumor necrosis factor alpha-induced liver injury through distinct pathways. Hepatology , 1995, 22:1829-1837.
9 Morales RM, Jimenez M, Ros J, et al. Nitric oxide production by peritoneal macrophages of cirrhotic rats: a host response against bacterial peritonitis. Gastroenterology , 1997, 112:2056-2064.
10 Gasini A, Ceni E, Salzano R, et al. Neutrophil-derived superoxide anion induces lipid peroxidation and stimulates collagen synthesis in human hepatic stellate cells: role of nitric oxide. Hepatology , 1997, 25:361-367.
11 Sharara AI, Perkins DJ, Misukonis MA, et al. Interferon(IFN)-alpha activation of human blood mononuclear cells in vitro and in vivo for nitric oxide synthase( NOS) type 2 mRNA and protein expression: possible relationship of induced NOS2 to the anti-hepatitis C effects of IFN-alpha in vivo. J Exp Med,1997, 186:1495-1502.
12 Vogl S,Junk
er U, Vogelsang H,et al. Macrophages from rat livers with micronodular and macronodular cirrhosis differ with respect to mediator release and DNA-synthesi上一页 [1] [2] [3] [4] 下一页
您现在的位置： 绿色健康网 >> 医学论文 >> 内科论文 >> 正文